ArticleCancers2022

Can HER2 1+ Breast Cancer Be Considered as HER2-Low Tumor? A Comparison of Clinicopathological Features, Quantitative HER2 mRNA Levels, and Prognosis among HER2-Negative Breast Cancer.

Lan Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.